The survival of children diagnosed with cancer has dramatically improved over the last 10 years. However, for children diagnosed with diffuse intrinsic pontine glioma (DIPG), a form of diffuse midline glioma (DMG), there are no effective pharmacological or immunological treatments available; median survival remains less than 10 months. In Australia, 101 children under the age of 15 die from cancer each year. Although incidence is seemingly rare, DMG including DIPG are responsible for 25% of these deaths.
Until Josie’s diagnosis, Matt’s research was focused on blood cancers, plus breast and colon cancers to a lesser degree. His research expertise saw him secure not one, but two, Early Career Fellowships via Cancer Institute NSW (2014-2016 and 2017-2019). Of such high quality was his work throughout, he was awarded the NSW Premier’s Award for Outstanding Research Fellow in 2019. In addition to the sound scientific research this award highlights, it is also given to those who actively engage with lay and scientific audiences, advocating scientific research and the development of community and industry linkage. Connecting with donors big and small Matt’s gracious receipt of a donation to RUN DIPG via Newcastle Permanent’s annual staff’s charitable donation scheme.
If you would like to organise a similar donation program through your employer or place of business, email email@example.com.